One study found that weight loss drug users were 66% more likely to develop stomach paralysis when compared to people who didnt take the medication
Research demonstrates that these medicines affect early disease development by addressing critical pathophysiological mechanisms
Both products contain the same active ingredients and dosage formulations but are marketed under different brand names in the US for diabetes (Mounjaro) and weight loss (Zepbound)
Cardiovascular outcomes Semaglutide has the most cardiovascular data
While it is a promising option to increase muscle mass via faster recovery times, aiding in fat loss via improved metabolism, and potentially improving the overall vitality of the bodybuilders, it all comes with a considerable cost to pay
Association with other diseases Due to the polygenic nature of vitiligo, it is frequently associated with several autoimmune or autoinflammatory diseases, namely, thyroid disorders (Kasumagic-Halilovic et al
